Kapidex and Reglan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kapidex (dexlansoprazole) and Reglan (metoclopramide hydrochloride). Common drug interactions include abdominal pain upper among females and postoperative wound infection among males.

The phase IV clinical study analyzes what interactions people have when they take Kapidex and Reglan. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Kapidex?

Kapidex has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 969 Kapidex users. Check the latest studies of Kapidex.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.



On Jul, 12, 2026

19 people who take Kapidex and Reglan together, and have interactions are studied.

Kapidex and Reglan drug interactions.

What are the common drug interactions of Kapidex and Reglan, by gender? *:

female:

  1. Abdominal pain upper
  2. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  3. Cholecystitis chronic (long lasting infection of gallbladder)
  4. Diarrhoea
  5. Chronic kidney disease
  6. Renal failure (kidney dysfunction)
  7. Actinic keratosis (skin disease due to sun exposure)
  8. Blood pressure decreased
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Mobility decreased (ability to move is reduced)

male:

  1. Postoperative wound infection
  2. Abdominal pain
  3. Pain in extremity
  4. Vomiting
  5. Abdominal wound dehiscence (abdominal wound ruptures)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Asthenia (weakness)
  8. Body temperature increased
  9. Chills (felling of cold)
  10. Diarrhoea

What are the common drug interactions of Kapidex and Reglan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain upper
  2. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  3. Cholecystitis chronic (long lasting infection of gallbladder)
  4. Diarrhoea

30-39:

  1. Postoperative wound infection

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Parosmia (distortion of the sense of smell, as in smelling odours that are not present)

60+:

  1. Abdominal pain
  2. Asthenia (weakness)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Pain in extremity
  5. Renal failure (kidney dysfunction)
  6. Vomiting
  7. Abdominal wound dehiscence (abdominal wound ruptures)
  8. Blood pressure decreased
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Cellulitis (infection under the skin)

What are the existing conditions these people have? *

  1. Acne (skin problems that cause pimples): 4 people, 21.05%
  2. Birth Control: 4 people, 21.05%
  3. Constipation: 4 people, 21.05%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 15.79%
  5. High Blood Pressure: 2 people, 10.53%
  6. Anaemia (lack of blood): 2 people, 10.53%
  7. Bacterial Infection: 2 people, 10.53%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.53%
  9. Essential Tremor: 2 people, 10.53%
  10. High Blood Cholesterol: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Kapidex and Reglan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kapidex and Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kapidex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kapidex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reglan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dexlansoprazole and metoclopramide hydrochloride (the active ingredients of Kapidex and Reglan, respectively), and Kapidex and Reglan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: